About Corona Remedies
Corona Remedies is a company based in Ahmedabad (India) founded in 2004 by Viral Bhupendrabhai Sitwala, Niravkumar Kirtikumar Mehta, and Ankur Kirtikumar Mehta.. Corona Remedies has raised $14.9 million across 1 funding round from investors including Creador. The company has 4,436 employees as of December 29, 2024. Corona Remedies offers products and services including Women's Healthcare Products and Pain Management Products.
- Headquarter Ahmedabad, India
- Employees 4436 as on 29 Dec, 2024
- Founders Viral Bhupendrabhai Sitwala, Niravkumar Kirtikumar Mehta, Ankur Kirtikumar Mehta
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Corona Remedies Limited
-
Annual Revenue
$139.99 M (USD)17.94as on Mar 31, 2025
-
Net Profit
$17.44 M (USD)65.11as on Mar 31, 2025
-
EBITDA
$28.21 M (USD)45.11as on Mar 31, 2025
-
Total Equity Funding
$14.9 M (USD)
in 1 rounds
-
Latest Funding Round
$14.9 M (USD), Series A
Jul 14, 2016
- Investors
-
Employee Count
4436
as on Dec 29, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Corona Remedies
Corona Remedies is a publicly listed company on the NSE with ticker symbol CORONA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Corona Remedies
Corona Remedies offers a comprehensive portfolio of products and services, including Women's Healthcare Products and Pain Management Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for women's healthcare are provided by CORONA Remedies in various therapeutic areas.
Products for pain management are offered by CORONA Remedies as part of their pharmaceutical lineup.
Funding Insights of Corona Remedies
Corona Remedies has successfully raised a total of $14.9M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.9 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $14.9M
-
First Round
First Round
(14 Jul 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Series A - Corona Remedies | Valuation | Creador |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Corona Remedies
Corona Remedies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Creador. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focusing on partnerships in consumer, healthcare, and business services across Southeast Asia and India.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Corona Remedies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Corona Remedies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corona Remedies Comparisons
Competitors of Corona Remedies
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corona Remedies
Frequently Asked Questions about Corona Remedies
When was Corona Remedies founded?
Corona Remedies was founded in 2004 and raised its 1st funding round 12 years after it was founded.
Where is Corona Remedies located?
Corona Remedies is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Is Corona Remedies a funded company?
Corona Remedies is a funded company, having raised a total of $14.9M across 1 funding round to date. The company's 1st funding round was a Series A of $14.9M, raised on Jul 14, 2016.
How many employees does Corona Remedies have?
As of Dec 29, 2024, the latest employee count at Corona Remedies is 4,436.
What is the annual revenue of Corona Remedies?
Annual revenue of Corona Remedies is $139.99M as on Mar 31, 2025.
What does Corona Remedies do?
Corona Remedies was established in 2004 in Ahmedabad, India, within the pharmaceutical sector. Oral solid medications are produced at two facilities, one holding EU-GMP and WHO certifications, the other certified by WHO-GMP. A hormone manufacturing facility is under development. Operations address womens health, cardio-diabetology, pain management, and urology through complex processes and varied drug delivery systems.
What products or services does Corona Remedies offer?
Corona Remedies offers Women's Healthcare Products and Pain Management Products.
Is Corona Remedies publicly traded?
Yes, Corona Remedies is publicly traded on NSE under the ticker symbol CORONA.
Who are Corona Remedies's investors?
Corona Remedies has 1 investor. Key investors include Creador.
What is Corona Remedies's ticker symbol?
The ticker symbol of Corona Remedies is CORONA on NSE.
What is Corona Remedies's valuation?
The valuation of Corona Remedies is $90.03M as of Jul 2016.